Company: APXIF
Filing Date: 2025-07-03
Form Type: F-4/A
Source: 0001213900-25-061545
Chunk: 228

Company: APx Acquisition Corp. I
Filing Date: 2025-07-03
Form: F-4/A
Chunk 228
---
00 per Private Placement Warrant. To the extent APx issues ordinary shares to effectuate the Business Combination, the potential for the issuance of a substantial number of additional ordinary shares upon exercise of these APx Warrants could make APx a less attractive acquisition vehicle. Such APx Warrants, when exercised, will increase the number of issued and outstanding ordinary shares and reduce the value of the ordinary shares issued to complete the Business Combination. The holders of Public Warrants, regardless of whether they redeem Public Shares, would retain the Public Warrants they own. Because the Public Warrants will remain outstanding and become Company Warrants regardless of the level of redemptions of Public Shares, as redemptions of Public Shares increase, the holders of Public Warrants who exercise such warrants will ultimately own a greater interest in the Company because there would be fewer Company Shares outstanding overall. The holders of Public Warrants, regardless of whether they redeem Public Shares, would retain 8,625,000 Public Warrants, which will become Company Warrants, with a market value of approximately $based on the closing price of $per Public Warrant on the Record Date. Because the Public Warrants will remain outstanding and become Company Warrants regardless of the level of redemptions of Public Shares, as redemptions of Public Shares increase, the holders of Public Warrants who exercise such warrants will ultimately own a greater interest in the Company because there would be fewer Company Shares outstanding overall. The SPAC Warrant Agreement designates the courts of the State of New York or the United States District Court for the Southern District of New York as the sole and exclusive forum for certain types of actions and proceedings that may be initiated by holders of APx Warrants, which could limit the ability of warrant holders to obtain a favorable judicial forum for disputes with APx. The SPAC Warrant Agreement provides that, subject to applicable law, (i) any action, proceeding or claim against us arising out of or relating in any way to the SPAC Warrant Agreement, including under the Securities Act, will be brought and enforced in the courts of the State of New York or the United States District Court for the Southern 93 District of New York and (ii) APx irrevocably submits to such jurisdiction, which jurisdiction shall be the exclusive forum for any such action, proceeding or claim. APx will waive any objection to such exclusive jurisdiction and that such courts represent an inconvenient forum. Notwithstanding the foregoing, these provisions of the SPAC Warrant Agreement will not apply to